Global Assistive Reproductive Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Assistive Reproductive Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Assisted reproductive technology (ART) are the medical procedures used for infertility treatment, in which eggs are surgically removed from the ovaries and are combined with the sperms in a laboratory.
Assistive Reproductive report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Assistive Reproductive market is projected to reach US$ 38130 million in 2033, increasing from US$ 28150 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2033. Demand from Fertility Clinics and IVF Center are the major drivers for the industry.
The Assisted Reproductive Technology (ART) market is primarily driven by the increasing demand for fertility treatments and solutions to overcome infertility challenges. ART encompasses a range of medical procedures and technologies that aid individuals and couples in achieving pregnancy. The growing prevalence of infertility due to various factors such as age, lifestyle, and medical conditions, coupled with advancements in reproductive medicine and technology, contributes to market growth. Moreover, the demonstrated success of ART methods such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in helping couples conceive further propels adoption. However, challenges include addressing ethical considerations, optimizing treatment protocols, and managing the emotional and psychological aspects of fertility treatments. Navigating legal regulations, ensuring affordability and accessibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in reproductive health, collaborations between fertility clinics and medical manufacturers, and comprehensive patient education on the benefits and potential challenges of using ART while addressing the evolving challenges associated with infertility treatment and family planning.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Assistive Reproductive market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Cooper Surgical
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
Segment by Type
In-vitro fertilization (IVF)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Other
Fertility Clinics
IVF Center
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Assistive Reproductive market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Assistive Reproductive introduction, etc. Assistive Reproductive Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Assistive Reproductive market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Assistive Reproductive report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Assistive Reproductive market is projected to reach US$ 38130 million in 2033, increasing from US$ 28150 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2033. Demand from Fertility Clinics and IVF Center are the major drivers for the industry.
The Assisted Reproductive Technology (ART) market is primarily driven by the increasing demand for fertility treatments and solutions to overcome infertility challenges. ART encompasses a range of medical procedures and technologies that aid individuals and couples in achieving pregnancy. The growing prevalence of infertility due to various factors such as age, lifestyle, and medical conditions, coupled with advancements in reproductive medicine and technology, contributes to market growth. Moreover, the demonstrated success of ART methods such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in helping couples conceive further propels adoption. However, challenges include addressing ethical considerations, optimizing treatment protocols, and managing the emotional and psychological aspects of fertility treatments. Navigating legal regulations, ensuring affordability and accessibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in reproductive health, collaborations between fertility clinics and medical manufacturers, and comprehensive patient education on the benefits and potential challenges of using ART while addressing the evolving challenges associated with infertility treatment and family planning.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Assistive Reproductive market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Cooper Surgical
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
Segment by Type
In-vitro fertilization (IVF)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Other
Segment by Application
Fertility Clinics
IVF Center
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Assistive Reproductive market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Assistive Reproductive introduction, etc. Assistive Reproductive Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Assistive Reproductive market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.